ArticleJournal of hematology & oncology2020

Preclinical efficacy for a novel tyrosine kinase inhibitor, ArQule 531 against acute myeloid leukemia.

Ola A Elgamal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.